Histological and 1H magnetic resonance spectroscopic imaging analysis of quinolinic acid-induced damage to the rat striatum

Magnetic Resonance in Medicine

Volumn 37, Issue 1, 1997, Pages 24-33

  Strauss, Ian ^a   Williamson, John M ^b   Bertram, Edward H ^b   Lothman, Eric W ^b   Fernandez, Erik J ^a  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

magnetic resonance; N acetyl aspartate; quinolinic acid; striatum

Indexed keywords

DAMAGE DETECTION; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETISM; NEURONS; PYRIDINE; RATS; SHRINKAGE; SPECTROSCOPIC ANALYSIS; TISSUE;

CELL VIABILITY; DEGREE OF DAMAGES; HISTOLOGICAL ANALYSIS; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; N-ACETYL ASPARTATE; NEUROLOGICAL DISEASE; PARTIAL VOLUME EFFECT; STRIATUM;

MAGNETIC RESONANCE;

CHOLINE; CREATINE; N ACETYLASPARTIC ACID; QUINOLINIC ACID; ASPARTIC ACID; DIAGNOSTIC AGENT; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN TISSUE; DIAGNOSTIC IMAGING; HISTOLOGY; MALE; NERVE CELL LESION; NEUROLOGIC DISEASE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; ANIMAL; CELL COUNT; CELL SURVIVAL; COMPARATIVE STUDY; CORPUS STRIATUM; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; NERVE CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT;

ANIMALS; ASPARTIC ACID; CELL COUNT; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEURONS; QUINOLINIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY;

EID: 0030614781     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910370106     Document Type: Article

References (31)

1. H. H. Tallan, Studies on the distribution of N-acetyl-L-aspartic acid in brain. J. Biol. Chem. 244, 41-45 (1957).
2. 1H NMR spectroscopic studies of brain. Neurosci. Biobehav. Rev. 13, 23-31 (1989).
3. J. Urenjak, S. R. Williams, D. G. Gadian, M. Noble, Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981-989 (1993).
4. H. Lanfermann, H. Kugel, W. Heindel, K. Herholz, W.-D. Heiss, K. Lackner, Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging. Radiology 186, 203-210 (1995).
5. P. B. Barker, J. H. Gillard, P. C. M. van Zijl, B. J. Soher, D. F. Hanley, A. M. Agildere, S. M. Oppenheimer, R. N. Bryan, Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 192, 723-732 (1994).
6. O. A. C Petroff, G. D. Graham, A. M. Blamire, M. Al-Rayess, D. L. Rothman, P. B. Fayad, L. M. Brass, R. G. Shuiman, J. W. Prichard, Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology 42, 1349-1354 (1992).
7. H. Hetherington, R. Kuzniecky, J. Pan, G. Mason, R. Morawetz, C. Harris, E. Faught, T. Vaughan, G. Pohost, Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann. Neurol. 38, 396-404 (1995).
8. F. Cendes, F. Andermann, M. C. Preul, D. L. Arnold, Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Ann. Neural. 35, 211-216 (1994).
9. P. M. Matthews, F. Andermann, K. Silver, G. Karpati, D. L. Arnold, Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 43, 2484-2490 (1993).
10. J. W. Hugg, K. D. Laxer, G. B. Matson, A. A. Maudsley, M. W. Weiner, Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Ann. Neurol. 34, 788-794 (1993).
11. 1H magnetic resonance spectroscopic imaging. J. Cereb. Blood Flow Metab. 14, 373-382 (1994).
12. A. C. Foster, W. O. Whetsell, Jr., E. D. Bird, R. Schwarcz, Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum. Brain Res. 336, 207-214 (1985).
13. R. Schwarcz, C. Köhler, Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci. Lett. 38, 85-90 (1983).
14. R. Schwarcz, W. O. Whetsell, Jr., R. M. Mangano, Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219, 316-318 (1983).
15. 1H spectroscopic imaging of cerebral metabolites in the rat using surface coils. Magn. Reson. Med. 10, 965-974 (1992).
16. Z. Starcuk, V. Sklenar, New hard pulse sequences for solvent signal suppression in Fourier transform NMR. II. J. Magn. Reson. 66, 391-397 (1986).
17. A. A. Maudsley, E. Lin, M. W. Weiner, Spectroscopic imaging display and analysis. Magn. Reson. Imaging 10, 471-485 (1992).
18. A. A. Maudsley, Z. Wu, M. W. Weiner, Automatic processing of MR spectroscopic images, in "Proc., SMRM, 12th Annual Meeting, 1993," p. 510.
19. K. J. Koller, R. Zaczek, J. T. Goyle, N-Acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J. Neurochem. 43, 1136-1142 (1984).
20. A. Macaya, R. E. Burke, Effect of striatal lesion with quinolinate on the development of substantia nigra dopaminergic neurons: a quantitative morphological analysis. Dev. Neurosci, 14, 362-368 (1992).
21. S. W. Davies, P. J. Roberts, No evidence for preservation of samatostatin-containing neurons after intrastriatal injections of quinolinic acid. Nature 327, 326-329 (1987).
22. 1H NMR spectroscopy in vivo. Nucl. Magn. Reson. Biomed. 7, 231-236 (1994).
23. 1H NMR. Magn. Reson. Med. 7, 425-431 (1988).
24. 1H NMR spectra by optimization of signal acquisition and processing and by incorporation of prior knowledge into the spectral fitting. Magn. Reson. Med. 15, 305-319 (1990).
25. 1H NMR spectroscopy. Magn. Reson. Med. 4, 575-581 (1987).
26. 2 relaxation time of ethanol and cerebral metabolites in vivo. Magn. Reson. Med. 23, 333-345 (1992).
27. D. E. Saunders, F. A. Howe, A. van den Boogaart, M. A. McLean, J. R. Griffiths, M. M. Brown, Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by shortecho proton spectroscopy. Stroke 28, 1007-1013 (1995).
28. 31P MR spectroscopic imaging. J. Cereb. Blood Flow Metab. 12, 734-744 (1992).
29. 1H magnetic resonance spectroscopy in the investigation of intractable epilepsy. Acta Neurol. Scand. 152, 116-121 (1994).
30. 1H magnetic resonance spectroscopy of rat brain extracts compared with Chromatographic methods. Neurochem. Res. 15, 1009-1016 (1990).
31. 1H magnetic resonance spectroscopic imaging. Neurology 43, 509-515 (1993).